Duru N, Pawar NR, Martin EW, Buzza MS, et al. Selective targeting of metastatic ovarian cancer using an engineered anthrax prodrug activated by membrane-anchored serine proteases. Proc Natl Acad Sci U S A 2022;119:e2201423119.
PMID: 35867758